维普中文期刊产品整合服务
25篇 您的检索式:作者名="Pellanda"
    题名 作者 年代 出处 被引量
1Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma:A Rare Cancer Network study显示文摘Objective: Primary uterine leiomyosarcomas(ULMS) are rare,and the optimal treatment is controversial.We aimed to assess the outcome and prognostic factors in a multicenter population of women treated for primary ULMS.Methods: We retrospectively collected data of 110 women treated in 19 institutions of the Rare Cancer Network(RCN).Inclusion criteria consisted of a pathology report confirming the diagnosis of ULMS,aged 18–80 years,complete International Federation of Gynecology and Obstetrics(FIGO) stage information,complete information on treatment,and a minimum follow-up of 6 months.Local control(LC) and locoregional control(LRC),overall survival(OS) and disease-free survival(DFS) rates were computed using the Kaplan-Meier method.Univariate analysis was implemented using the log rank test,and multivariate analysis using the Cox model.Results: All patients underwent surgery.Seventy-five patients(68%) received adjuvant radiotherapy(RT),including brachytherapy in 18(16%).Seventeen patients(15%) received adjuvant chemotherapy.Median follow-up was 58(range,6–240) months.Five-year OS and DFS rates were 50% and 34%,and LC and LRC rates were 88%and 72%,respectively.On multivariate analysis,independent favorable prognostic factors were younger age,FIGO stage I,small tumor size,previous uterine disease,and no vascular invasion for OS and DFS.FIGO stage was the only favorable factor influencing LRC.Adjuvant local or systemic treatments did not improve the outcomes.Eight patients treated with RT presented a grade 3 acute toxicity,and only one patient with grade 3 late toxicity.Conclusions: In this large population of primary ULMS patients,we found good results in terms of LC and LRC.Nevertheless,OS remains poor,mainly due to the occurrence of distant metastases.An early diagnosis seemed to improve the prognosis of the patients.Adjuvant local or systemic treatments,or more aggressive surgicalprocedures such as the Wertheim procedure,did not seem to impact the outcome.Alessandra Franzetti Pellanda Berardino De Bari Elisabeth Deniaud-Alexandre MarcoKrengli Paul Van Houtte Antonella Riehetti Salvador Villa Hadassah Goldberg EwaSzutowiez-Zielifiska Michel Bolla Heidi Rutten Marc Van Eijkeren Philip Poortmans Guido Henke Yavuz Anaeak Steve Chan Christine Landmann Carine Kirkove LueianoScandolaro Jacques Bernier Rene-Olivier Mirimanof Mahmut Ozsahin 2017Chinese Journal of Cancer Research2017,29,6:2
2C-reactive protein in acute coronary syndrome:association with 3-year outcomes显示文摘Schaan BD Pellanda LC Maciel PT 2009Braz J Med Biol Res2009,42,12:1
3C-reactive protein in acute coronary syndrome:association with 3-year outcomes显示文摘Schaan BD Pellanda LC Maciel PT 2009Braz J Med Biol Res2009,42,12:1
4C-reactive protein in acute coronary syndrome:association with 3-year outcomes显示文摘Schaan B D Pellanda L C Maciel P T 0,,12:1
5Fumonisin B1treatment acts synergistically with methyl donor deficiency during rat pregnancy to produce alterations of H3-and H4-histone methylation patterns in fetuses显示文摘PELLANDA H FORGES T BRESSENOT A 2012Mol Nutr Food Res2012,56,6:1
6Stimulus Parameters for Goldmann Kinetic Perimetry in Nonorganic Visual Loss显示文摘Ebneter Andreas Pellanda Niccolo Kunz Andrea Mojon Stefania Mojon Daniel S 2010Ophthalmologica2010,,3:1
7Pharmacokinetics of antifungal agents显示文摘Fabris A Pellanda M V Gardin C 1993Perit Dial Int1993,13,2:1
8The ' Happy Heart' educational program for changes in health habits in children and their families:protocol for a randomized clinical trial 显示文摘Minossi V Pellanda LC 2015BMC Pediatr2015,15,1:1
9I I guidelines of prevention of atherosclerosis in childhood and adolescence] 显示文摘Back Giuliano Ide C Caramelli B Pellanda L Duncan B Mattos S Fonseca F H Sociedade Brasileira de Cardiologia 2005Arq Bras Cardiol2005,856,:1
10Fumonisin Bl treatment acts synergistically with methyl donor deficiency during rat pregnancy to produce alterations of H3- and H4-histone methylation patterns in fetuses 显示文摘Pellanda H Forges T Bressenot A 2012Molecular Nutrition and Food Research2012,56,6:1
11C-reactive protein in acute coronary syndrome; association with 3-year outcomes显示文摘Schaan BD Pellanda LC Maciel PT 2009Braz J Med Biol Res2009,42,12:1
12Topical bioavailability of triamcinolone acetonide: effect of dose and application frequency显示文摘Carolina Pellanda Evelyne Ottiker Christoph Strub Verena Figueiredo Theo Rufli Georgios Imanidis Christian Surber 2006Archives of Dermatological Research2006,,5:1
13Topical bioavailability of triamcinolone acetonide: effect of dose and application frequency 显示文摘PELLANDA C OTTIKER E STRUB C 2006Arch Dermatol Res2006,298,5:1
14Glycemia and inflamma tory markers in acute coronary syndrome:association with late post hospital outcomes 显示文摘Maciel PT Pellanda LC Portal VL 2007Diabetes Research & Clinical Practice2007,78,2:1
15Morel-Lavallée lesion in the knee:A case report显示文摘Pitrez EH Pellanda RC Silva ME 2010Radiologia Brasileira2010,43,5:1
16Inflammatory markers of cardiovascular disease in the elderly 显示文摘Adriane M Ramos Lucia Campos Pellanda 2009Arq Bras Cardiol2009,92,3:1
17Fumonisin FBItreatment acts synergistically with methyl donor deficiency duringrat pregnancy to produce alterations of H3- and H4-histonemethylation patterns in fetuses显示文摘Pellanda H Forges T Bressenot A 2012Mol Nutr Food Res2012,56,6:1
18C-reactive protein in acute coronary syndrome:as-sociation with3-year outcomes显示文摘SCHAAN B D PELLANDA L C MACIEL P T 2009Braz J Med Biol Res2009,42,:1
19Glycemia and inflammatory markers in acute coronary syndrome:association with late post-hospital outcomes显示文摘Maciel PT Pellanda LC Portal VL 2007Diabetes Res Clin Pract2007,78,:1
20Mixed H2/H∞ multi-channel linear parameter-varying control in discrete time 显示文摘APKARIAN P PELLANDA P C TUAN H D 2000Systems & Control Letters2000,41,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费